An environmentally friendly, FDA-compatible paper coating technology using ammonium zirconium carbonate (AZC) to crosslink starch nanoparticles (biolatex) with electrosterically stabilized nanocrystalline cellulose (ENCC). The composite delivers strong mechanical reinforcement and excellent barrier properties at low nanoparticle loadings, offering a polystyrene-free solution for disposable paper products such as plates and cups.
This technology offers an all-green, polystyrene-free reinforcing nanocomposite for paper coating applications. It addresses the growing need for sustainable alternatives to synthetic coatings used in disposable paper products such as plates and cups. By combining starch nanoparticles (biolatex) with a novel electrosterically stabilized nanocrystalline cellulose (ENCC), the composite is crosslinked using FDA-approved ammonium zirconium carbonate (AZC). The result is a mechanically robust coating with strong barrier properties, produced through a simple, low-temperature heating process that is compatible with existing paper manufacturing workflows.
The technology is currently at an early-to-mid stage of development. Promising preliminary results have validated the core hypothesis, demonstrating significant mechanical reinforcement and barrier performance of AZC-crosslinked biolatex and nanocellulose composites on paper substrates. Next steps involve engineering and scaling the AZC-based crosslinking process for coating paper materials and validating performance against widely used polystyrene-based disposable products. Further work will focus on process optimization, pilot-scale coating trials, and assessment of long-term durability and barrier performance under real-world conditions.
Penn State University is a comprehensive public land‑grant research university with a large multi‑campus footprint across Pennsylvania. Industry engages through a research and technology park adjacent to the flagship campus that houses corporate R&D, co‑located labs, and flexible collaboration space, as well as a statewide extension network that enables field testing, demonstration, and workforce reach. Integration with a major hospital system supports clinical translation, and an applied research laboratory fosters mission‑driven partnerships with government and industry sponsors. Research is supported by competitive federal funding from agencies such as NSF, NIH, DOE, USDA, DoD, and NASA. A dedicated technology transfer office manages IP, licensing, and startup formation to accelerate commercialization.